Are you a biopharmaceutical or biotech professional looking to stay ahead in the industry? Download our comprehensive Q&A-style interview to gain exclusive insights into our significant capacity expansion at our Stein, Switzerland facility.
What’s Inside?
This Q&A format discussion provides an in-depth look into our recent investment of 500 Mn CHF in expanding our large-scale commercial manufacturing capabilities. You will discover the state-of-the-art 20,000 m2 facility designed for GMP Annex-1 compliance, featuring advanced automation, precision filling, and sustainability initiatives like solar panels and renewable-sourced black steam.
We explain how this expansion complements our existing drug product network, including the integration of isolator technologies and Single-Use-Systems (SUS) across our Stein and Visp sites. You will get the latest updates on the project timeline, with the facility expected to be operational from the first half of 2027.
Learn how biopharmaceutical and biotech companies can benefit from increased capacity, supply-chain simplification, and agile responses to market needs. Explore our commitment to forming long-term, trusted partnerships with our customers, supported by our extensive experience in tech transfers and predictive tools.
Why Download?
Stay informed with the latest advancements in large-scale commercial manufacturing and understand how they can impact your business. Learn how to optimize your supply chain by partnering with an integrated drug substance and drug product manufacturer. Understand how our expansion can help you respond to changing market demands with flexible and scalable solutions. Gain insights into our commitment to innovation and customer-centric partnerships that drive success.
Offered Free by: Lonza
See All Resources from: Lonza
